1区 · 医学
Article
作者: Leenaerts, Joseph E. ; te Riele, Paula ; Xia, Chunfang A. ; Iturrino, Laura ; Song, Fengbin ; Vandenberghe, Rik ; Kolb, Hartmuth ; Andres, Jose-Ignacio ; Rombouts, Frederik J. R. ; Bormans, Guy ; Wuyts, Stijn ; Bottelbergs, Astrid ; Declercq, Lieven ; Wintmolders, Cindy ; Moechars, Diederik ; Chen, Lu ; Marien, Jonas
In Alzheimer's disease, the density and spread of aggregated tau protein track well with neurodegeneration and cognitive decline, making the imaging of aggregated tau a compelling biomarker. A structure-activity relationship exploration around an isoquinoline hit, followed by an exploration of tolerated fluorination positions, allowed us to identify 9 (JNJ-64326067), a potent and selective binder to aggregated tau with a favorable pharmacokinetic profile and no apparent off-target binding. This was confirmed in rat and monkey positron emission tomography studies using [18F]9.